open access

Vol 2, No 3 (2017)
CASE REPORTS
Published online: 2017-12-28
Get Citation

Neurotrophic keratopathy — case reports analysis and management

Ioannis Mallias, Panagiota Mylova, Anastasia Tassiopoulou
DOI: 10.5603/OJ.2017.0020
·
Ophthalmol J 2017;2(3):91-99.

open access

Vol 2, No 3 (2017)
CASE REPORTS
Published online: 2017-12-28

Abstract

This is a case series of patients suffering from neurotrophic keratopathy. The main categorisation of the disease is discussed as well as the management that should be followed on each stage. Several cases of patients with neurotrophic keratopathy are analysed and the treatment (different on every patient) of them is presented. Newer substances that are beginning to be used in the treatment of neurotrophic keratopathy are discussed as well.

Abstract

This is a case series of patients suffering from neurotrophic keratopathy. The main categorisation of the disease is discussed as well as the management that should be followed on each stage. Several cases of patients with neurotrophic keratopathy are analysed and the treatment (different on every patient) of them is presented. Newer substances that are beginning to be used in the treatment of neurotrophic keratopathy are discussed as well.
Get Citation

Keywords

neurotrophic keratopathy, cornea, corneal perforation, corneal ulcers, herpetic keratitis, penetrating keratoplasty, neurotrophic ulcer

About this article
Title

Neurotrophic keratopathy — case reports analysis and management

Journal

Ophthalmology Journal

Issue

Vol 2, No 3 (2017)

Pages

91-99

Published online

2017-12-28

DOI

10.5603/OJ.2017.0020

Bibliographic record

Ophthalmol J 2017;2(3):91-99.

Keywords

neurotrophic keratopathy
cornea
corneal perforation
corneal ulcers
herpetic keratitis
penetrating keratoplasty
neurotrophic ulcer

Authors

Ioannis Mallias
Panagiota Mylova
Anastasia Tassiopoulou

References (19)
  1. Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014; 8: 571–579.
  2. Kauffmann T, Bodanowitz S, Hesse L, et al. Corneal reinnervation after photorefractive keratectomy and laser in situ keratomileusis: an in vivo study with a confocal videomicroscope. Ger J Ophthalmol. 1996; 5(6): 508–512.
  3. Wilson SE. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy. Ophthalmology. 2001; 108(6): 1082–1087.
  4. Wilson SE, Ambrósio R. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. Am J Ophthalmol. 2001; 132(3): 405–406.
  5. Netto MV, Mohan RR, Ambrósio R, et al. Gene therapy in the cornea. Prog Retin Eye Res. 2005; 24(5): 537–559.
  6. Lin X, Xu B, Sun Y, et al. Comparison of deep anterior lamellar keratoplasty and penetrating keratoplasty with respect to postoperative corneal sensitivity and tear film function. Graefes Arch Clin Exp Ophthalmol. 2014; 252(11): 1779–1787.
  7. Wasilewski D, Mello GHR, Moreira H. Impact of collagen crosslinking on corneal sensitivity in keratoconus patients. Cornea. 2013; 32(7): 899–902.
  8. Banerjee PJ, Chandra A, Sullivan PM, et al. Neurotrophic corneal ulceration after retinal detachment surgery with retinectomy and endolaser: a case series. JAMA Ophthalmol. 2014; 132(6): 750–752.
  9. Tinley CG, Gray RH. Routine, single session, indirect laser for proliferative diabetic retinopathy. Eye (Lond). 2009; 23(9): 1819–1823.
  10. Lockwood A, Hope-Ross M, Chell P. Neurotrophic keratopathy and diabetes mellitus. Eye (Lond). 2006; 20(7): 837–839.
  11. Mackie IA. Neuroparalytic keratitis. In: Fraunfelder F, Roy FH, Meyer SM. ed. Current ocular therapy. WB Saunders, Philadelphia, PA: 1995: 452–454.
  12. Hersh PS, Rice BA, Baer JC, et al. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol. 1990; 108(4): 577–583.
  13. Jeng BH, Dupps WJ. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea. 2009; 28(10): 1104–1108.
  14. Turkoglu E, Celik E, Alagoz G. A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis. Semin Ophthalmol. 2014; 29(3): 119–126.
  15. Bonini S, Rama P, Olzi D, et al. Neurotrophic keratitis. Eye (Lond). 2003; 17(8): 989–995.
  16. Aifa A, Gueudry J, Portmann A, et al. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Invest Ophthalmol Vis Sci. 2012; 53(13): 8181–8185.
  17. http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/cenegermin-receives-european-commission-marketing-authorization.
  18. Faulkner WJ, Varley GA. Corneal diagnostic techniques. In: Krachmer JH, Mannis MJ, Holland EJ. ed. Cornea. Elsevier/Mosby, Philadelphia 2005: 229–235.
  19. Aslanides IM, Selimis VD, Bessis NV, et al. A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA). Clin Ophthalmol. 2015; 9: 685–690.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl